nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—ABCC2—esophageal cancer	0.337	0.731	CbGaD
Phenytoin—ABCB1—esophageal cancer	0.124	0.269	CbGaD
Phenytoin—SLCO1C1—Methotrexate—esophageal cancer	0.0998	0.296	CbGbCtD
Phenytoin—ABCC2—Carboplatin—esophageal cancer	0.0514	0.153	CbGbCtD
Phenytoin—ABCC2—Cisplatin—esophageal cancer	0.0439	0.13	CbGbCtD
Phenytoin—CYP2C9—Capecitabine—esophageal cancer	0.0293	0.0869	CbGbCtD
Phenytoin—ABCC2—Methotrexate—esophageal cancer	0.0285	0.0846	CbGbCtD
Phenytoin—CYP2B6—Cisplatin—esophageal cancer	0.0279	0.0829	CbGbCtD
Phenytoin—ALB—Methotrexate—esophageal cancer	0.0178	0.0527	CbGbCtD
Phenytoin—CYP2C9—Cisplatin—esophageal cancer	0.0148	0.0438	CbGbCtD
Phenytoin—ABCB1—Cisplatin—esophageal cancer	0.0143	0.0425	CbGbCtD
Phenytoin—ABCB1—Methotrexate—esophageal cancer	0.0093	0.0276	CbGbCtD
Phenytoin—Oxaprozin—PTGS1—esophageal cancer	0.000501	0.168	CrCbGaD
Phenytoin—Face oedema—Cisplatin—esophageal cancer	0.000391	0.00389	CcSEcCtD
Phenytoin—Fluid retention—Capecitabine—esophageal cancer	0.000391	0.00388	CcSEcCtD
Phenytoin—Gingivitis—Methotrexate—esophageal cancer	0.00039	0.00388	CcSEcCtD
Phenytoin—Necrosis—Methotrexate—esophageal cancer	0.00039	0.00388	CcSEcCtD
Phenytoin—Irritability—Cisplatin—esophageal cancer	0.000387	0.00384	CcSEcCtD
Phenytoin—Dehydration—Cisplatin—esophageal cancer	0.000377	0.00374	CcSEcCtD
Phenytoin—Phenobarbital—CYP1B1—esophageal cancer	0.000374	0.126	CrCbGaD
Phenytoin—Petechiae—Methotrexate—esophageal cancer	0.000373	0.0037	CcSEcCtD
Phenytoin—Urine output increased—Capecitabine—esophageal cancer	0.000372	0.00369	CcSEcCtD
Phenytoin—Ecchymosis—Capecitabine—esophageal cancer	0.000372	0.00369	CcSEcCtD
Phenytoin—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00037	0.00368	CcSEcCtD
Phenytoin—Hypokalaemia—Cisplatin—esophageal cancer	0.000369	0.00366	CcSEcCtD
Phenytoin—Breast disorder—Cisplatin—esophageal cancer	0.000366	0.00364	CcSEcCtD
Phenytoin—Apnoea—Methotrexate—esophageal cancer	0.000362	0.00359	CcSEcCtD
Phenytoin—Sepsis—Capecitabine—esophageal cancer	0.000357	0.00355	CcSEcCtD
Phenytoin—Mental disability—Capecitabine—esophageal cancer	0.000357	0.00355	CcSEcCtD
Phenytoin—Speech disorder—Methotrexate—esophageal cancer	0.000356	0.00354	CcSEcCtD
Phenytoin—Extravasation—Methotrexate—esophageal cancer	0.000351	0.00349	CcSEcCtD
Phenytoin—Ear pain—Capecitabine—esophageal cancer	0.00035	0.00348	CcSEcCtD
Phenytoin—Thrombophlebitis—Capecitabine—esophageal cancer	0.000345	0.00343	CcSEcCtD
Phenytoin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000342	0.00339	CcSEcCtD
Phenytoin—Polyuria—Capecitabine—esophageal cancer	0.00034	0.00338	CcSEcCtD
Phenytoin—Skin discolouration—Methotrexate—esophageal cancer	0.000339	0.00337	CcSEcCtD
Phenytoin—Deafness—Capecitabine—esophageal cancer	0.000334	0.00332	CcSEcCtD
Phenytoin—Pancytopenia—Cisplatin—esophageal cancer	0.000333	0.0033	CcSEcCtD
Phenytoin—Oliguria—Methotrexate—esophageal cancer	0.000333	0.0033	CcSEcCtD
Phenytoin—Phenylbutazone—PTGS1—esophageal cancer	0.000331	0.111	CrCbGaD
Phenytoin—Eye pain—Capecitabine—esophageal cancer	0.000331	0.00329	CcSEcCtD
Phenytoin—Dysarthria—Methotrexate—esophageal cancer	0.000324	0.00322	CcSEcCtD
Phenytoin—Amnesia—Capecitabine—esophageal cancer	0.000318	0.00316	CcSEcCtD
Phenytoin—Inflammation—Methotrexate—esophageal cancer	0.000316	0.00314	CcSEcCtD
Phenytoin—Carbamazepine—ABCC2—esophageal cancer	0.000313	0.105	CrCbGaD
Phenytoin—Purpura—Capecitabine—esophageal cancer	0.00031	0.00308	CcSEcCtD
Phenytoin—Renal failure—Cisplatin—esophageal cancer	0.000307	0.00305	CcSEcCtD
Phenytoin—Vaginal inflammation—Methotrexate—esophageal cancer	0.000306	0.00304	CcSEcCtD
Phenytoin—Pulmonary embolism—Methotrexate—esophageal cancer	0.000306	0.00304	CcSEcCtD
Phenytoin—Conjunctivitis—Cisplatin—esophageal cancer	0.000304	0.00301	CcSEcCtD
Phenytoin—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000299	0.00297	CcSEcCtD
Phenytoin—Diplopia—Capecitabine—esophageal cancer	0.000299	0.00297	CcSEcCtD
Phenytoin—Osteoarthritis—Capecitabine—esophageal cancer	0.000299	0.00297	CcSEcCtD
Phenytoin—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000296	0.00294	CcSEcCtD
Phenytoin—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000295	0.00293	CcSEcCtD
Phenytoin—Migraine—Capecitabine—esophageal cancer	0.000294	0.00292	CcSEcCtD
Phenytoin—Phenobarbital—ABCC2—esophageal cancer	0.000292	0.0979	CrCbGaD
Phenytoin—Vaginal infection—Methotrexate—esophageal cancer	0.000289	0.00287	CcSEcCtD
Phenytoin—Face oedema—Capecitabine—esophageal cancer	0.000289	0.00286	CcSEcCtD
Phenytoin—Phenobarbital—CYP2A6—esophageal cancer	0.000288	0.0968	CrCbGaD
Phenytoin—Oxaprozin—PTGS2—esophageal cancer	0.000287	0.0962	CrCbGaD
Phenytoin—Bradycardia—Cisplatin—esophageal cancer	0.000286	0.00283	CcSEcCtD
Phenytoin—Irritability—Capecitabine—esophageal cancer	0.000285	0.00283	CcSEcCtD
Phenytoin—Cardiac arrest—Capecitabine—esophageal cancer	0.000284	0.00282	CcSEcCtD
Phenytoin—Urinary retention—Capecitabine—esophageal cancer	0.000284	0.00282	CcSEcCtD
Phenytoin—Mood swings—Capecitabine—esophageal cancer	0.000283	0.00281	CcSEcCtD
Phenytoin—Ataxia—Capecitabine—esophageal cancer	0.000281	0.00279	CcSEcCtD
Phenytoin—Coma—Methotrexate—esophageal cancer	0.00028	0.00278	CcSEcCtD
Phenytoin—Dehydration—Capecitabine—esophageal cancer	0.000278	0.00276	CcSEcCtD
Phenytoin—Urine output increased—Methotrexate—esophageal cancer	0.000277	0.00275	CcSEcCtD
Phenytoin—Ecchymosis—Methotrexate—esophageal cancer	0.000277	0.00275	CcSEcCtD
Phenytoin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000276	0.00274	CcSEcCtD
Phenytoin—Connective tissue disorder—Cisplatin—esophageal cancer	0.000276	0.00274	CcSEcCtD
Phenytoin—Gynaecomastia—Methotrexate—esophageal cancer	0.000274	0.00272	CcSEcCtD
Phenytoin—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000273	0.00271	CcSEcCtD
Phenytoin—Abdominal pain upper—Capecitabine—esophageal cancer	0.000273	0.00271	CcSEcCtD
Phenytoin—Hypokalaemia—Capecitabine—esophageal cancer	0.000272	0.0027	CcSEcCtD
Phenytoin—Breast disorder—Capecitabine—esophageal cancer	0.00027	0.00268	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000269	0.00267	CcSEcCtD
Phenytoin—Sepsis—Methotrexate—esophageal cancer	0.000266	0.00264	CcSEcCtD
Phenytoin—Gastritis—Capecitabine—esophageal cancer	0.000264	0.00263	CcSEcCtD
Phenytoin—Muscular weakness—Capecitabine—esophageal cancer	0.000264	0.00262	CcSEcCtD
Phenytoin—Tinnitus—Cisplatin—esophageal cancer	0.000261	0.0026	CcSEcCtD
Phenytoin—Lymphadenopathy—Methotrexate—esophageal cancer	0.000261	0.00259	CcSEcCtD
Phenytoin—Influenza—Capecitabine—esophageal cancer	0.000258	0.00256	CcSEcCtD
Phenytoin—Asthma—Capecitabine—esophageal cancer	0.000258	0.00256	CcSEcCtD
Phenytoin—Dysphagia—Capecitabine—esophageal cancer	0.000258	0.00256	CcSEcCtD
Phenytoin—Thrombophlebitis—Methotrexate—esophageal cancer	0.000257	0.00255	CcSEcCtD
Phenytoin—Polyuria—Methotrexate—esophageal cancer	0.000253	0.00252	CcSEcCtD
Phenytoin—Immune system disorder—Cisplatin—esophageal cancer	0.000253	0.00251	CcSEcCtD
Phenytoin—Bronchitis—Capecitabine—esophageal cancer	0.000248	0.00247	CcSEcCtD
Phenytoin—Pancytopenia—Capecitabine—esophageal cancer	0.000245	0.00243	CcSEcCtD
Phenytoin—Dysuria—Capecitabine—esophageal cancer	0.000242	0.0024	CcSEcCtD
Phenytoin—Flatulence—Cisplatin—esophageal cancer	0.000241	0.00239	CcSEcCtD
Phenytoin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000236	0.00234	CcSEcCtD
Phenytoin—Muscle spasms—Cisplatin—esophageal cancer	0.000235	0.00233	CcSEcCtD
Phenytoin—Weight decreased—Capecitabine—esophageal cancer	0.000234	0.00232	CcSEcCtD
Phenytoin—Hyperglycaemia—Capecitabine—esophageal cancer	0.000233	0.00231	CcSEcCtD
Phenytoin—Pneumonia—Capecitabine—esophageal cancer	0.000232	0.0023	CcSEcCtD
Phenytoin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00023	0.00228	CcSEcCtD
Phenytoin—Tremor—Cisplatin—esophageal cancer	0.000229	0.00227	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000228	0.00227	CcSEcCtD
Phenytoin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000227	0.00225	CcSEcCtD
Phenytoin—Renal failure—Capecitabine—esophageal cancer	0.000226	0.00225	CcSEcCtD
Phenytoin—Anaemia—Cisplatin—esophageal cancer	0.000226	0.00224	CcSEcCtD
Phenytoin—Conjunctivitis—Capecitabine—esophageal cancer	0.000224	0.00222	CcSEcCtD
Phenytoin—Osteoarthritis—Methotrexate—esophageal cancer	0.000222	0.00221	CcSEcCtD
Phenytoin—Malaise—Cisplatin—esophageal cancer	0.00022	0.00219	CcSEcCtD
Phenytoin—Leukopenia—Cisplatin—esophageal cancer	0.000219	0.00217	CcSEcCtD
Phenytoin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000218	0.00216	CcSEcCtD
Phenytoin—Epistaxis—Capecitabine—esophageal cancer	0.000217	0.00216	CcSEcCtD
Phenytoin—Agranulocytosis—Capecitabine—esophageal cancer	0.000215	0.00213	CcSEcCtD
Phenytoin—Irritability—Methotrexate—esophageal cancer	0.000212	0.00211	CcSEcCtD
Phenytoin—Convulsion—Cisplatin—esophageal cancer	0.000212	0.0021	CcSEcCtD
Phenytoin—Mood swings—Methotrexate—esophageal cancer	0.000211	0.00209	CcSEcCtD
Phenytoin—Bradycardia—Capecitabine—esophageal cancer	0.00021	0.00209	CcSEcCtD
Phenytoin—Ataxia—Methotrexate—esophageal cancer	0.000209	0.00208	CcSEcCtD
Phenytoin—Myalgia—Cisplatin—esophageal cancer	0.000208	0.00206	CcSEcCtD
Phenytoin—Haemoglobin—Capecitabine—esophageal cancer	0.000208	0.00206	CcSEcCtD
Phenytoin—Rhinitis—Capecitabine—esophageal cancer	0.000207	0.00206	CcSEcCtD
Phenytoin—Haemorrhage—Capecitabine—esophageal cancer	0.000207	0.00205	CcSEcCtD
Phenytoin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000206	0.00204	CcSEcCtD
Phenytoin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000205	0.00204	CcSEcCtD
Phenytoin—Discomfort—Cisplatin—esophageal cancer	0.000205	0.00204	CcSEcCtD
Phenytoin—Pharyngitis—Capecitabine—esophageal cancer	0.000205	0.00204	CcSEcCtD
Phenytoin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000203	0.00202	CcSEcCtD
Phenytoin—Breast disorder—Methotrexate—esophageal cancer	0.000201	0.002	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.0002	0.00199	CcSEcCtD
Phenytoin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000199	0.00198	CcSEcCtD
Phenytoin—Infection—Cisplatin—esophageal cancer	0.000198	0.00197	CcSEcCtD
Phenytoin—Erythema multiforme—Capecitabine—esophageal cancer	0.000195	0.00194	CcSEcCtD
Phenytoin—Nervous system disorder—Cisplatin—esophageal cancer	0.000195	0.00194	CcSEcCtD
Phenytoin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000195	0.00194	CcSEcCtD
Phenytoin—Tachycardia—Cisplatin—esophageal cancer	0.000194	0.00193	CcSEcCtD
Phenytoin—Tinnitus—Capecitabine—esophageal cancer	0.000193	0.00191	CcSEcCtD
Phenytoin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000193	0.00191	CcSEcCtD
Phenytoin—Asthma—Methotrexate—esophageal cancer	0.000192	0.00191	CcSEcCtD
Phenytoin—Eosinophilia—Methotrexate—esophageal cancer	0.00019	0.00189	CcSEcCtD
Phenytoin—Anorexia—Cisplatin—esophageal cancer	0.00019	0.00189	CcSEcCtD
Phenytoin—Phenylbutazone—PTGS2—esophageal cancer	0.000189	0.0636	CrCbGaD
Phenytoin—Immune system disorder—Capecitabine—esophageal cancer	0.000187	0.00185	CcSEcCtD
Phenytoin—Hypotension—Cisplatin—esophageal cancer	0.000186	0.00185	CcSEcCtD
Phenytoin—Chills—Capecitabine—esophageal cancer	0.000186	0.00184	CcSEcCtD
Phenytoin—Pancytopenia—Methotrexate—esophageal cancer	0.000183	0.00181	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000182	0.0018	CcSEcCtD
Phenytoin—Diphenhydramine—PTGS1—esophageal cancer	0.00018	0.0606	CrCbGaD
Phenytoin—Dysuria—Methotrexate—esophageal cancer	0.00018	0.00178	CcSEcCtD
Phenytoin—Paraesthesia—Cisplatin—esophageal cancer	0.000179	0.00178	CcSEcCtD
Phenytoin—Dyspnoea—Cisplatin—esophageal cancer	0.000178	0.00176	CcSEcCtD
Phenytoin—Flatulence—Capecitabine—esophageal cancer	0.000177	0.00176	CcSEcCtD
Phenytoin—Dysgeusia—Capecitabine—esophageal cancer	0.000176	0.00175	CcSEcCtD
Phenytoin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000176	0.00174	CcSEcCtD
Phenytoin—Back pain—Capecitabine—esophageal cancer	0.000174	0.00173	CcSEcCtD
Phenytoin—Decreased appetite—Cisplatin—esophageal cancer	0.000173	0.00172	CcSEcCtD
Phenytoin—Muscle spasms—Capecitabine—esophageal cancer	0.000173	0.00172	CcSEcCtD
Phenytoin—Pneumonia—Methotrexate—esophageal cancer	0.000172	0.00171	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000172	0.00171	CcSEcCtD
Phenytoin—Drowsiness—Methotrexate—esophageal cancer	0.000171	0.0017	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00017	0.00169	CcSEcCtD
Phenytoin—Tremor—Capecitabine—esophageal cancer	0.000169	0.00167	CcSEcCtD
Phenytoin—Renal failure—Methotrexate—esophageal cancer	0.000169	0.00167	CcSEcCtD
Phenytoin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000167	0.00166	CcSEcCtD
Phenytoin—Conjunctivitis—Methotrexate—esophageal cancer	0.000167	0.00165	CcSEcCtD
Phenytoin—Anaemia—Capecitabine—esophageal cancer	0.000166	0.00165	CcSEcCtD
Phenytoin—Sweating—Methotrexate—esophageal cancer	0.000164	0.00163	CcSEcCtD
Phenytoin—Feeling abnormal—Cisplatin—esophageal cancer	0.000164	0.00163	CcSEcCtD
Phenytoin—Malaise—Capecitabine—esophageal cancer	0.000162	0.00161	CcSEcCtD
Phenytoin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000162	0.00161	CcSEcCtD
Phenytoin—Epistaxis—Methotrexate—esophageal cancer	0.000162	0.00161	CcSEcCtD
Phenytoin—Vertigo—Capecitabine—esophageal cancer	0.000162	0.00161	CcSEcCtD
Phenytoin—Syncope—Capecitabine—esophageal cancer	0.000161	0.0016	CcSEcCtD
Phenytoin—Leukopenia—Capecitabine—esophageal cancer	0.000161	0.0016	CcSEcCtD
Phenytoin—Agranulocytosis—Methotrexate—esophageal cancer	0.00016	0.00159	CcSEcCtD
Phenytoin—Palpitations—Capecitabine—esophageal cancer	0.000159	0.00158	CcSEcCtD
Phenytoin—Loss of consciousness—Capecitabine—esophageal cancer	0.000158	0.00157	CcSEcCtD
Phenytoin—Body temperature increased—Cisplatin—esophageal cancer	0.000158	0.00156	CcSEcCtD
Phenytoin—Cough—Capecitabine—esophageal cancer	0.000157	0.00156	CcSEcCtD
Phenytoin—Hypertension—Capecitabine—esophageal cancer	0.000155	0.00154	CcSEcCtD
Phenytoin—Haemoglobin—Methotrexate—esophageal cancer	0.000155	0.00154	CcSEcCtD
Phenytoin—Haemorrhage—Methotrexate—esophageal cancer	0.000154	0.00153	CcSEcCtD
Phenytoin—Arthralgia—Capecitabine—esophageal cancer	0.000153	0.00152	CcSEcCtD
Phenytoin—Chest pain—Capecitabine—esophageal cancer	0.000153	0.00152	CcSEcCtD
Phenytoin—Myalgia—Capecitabine—esophageal cancer	0.000153	0.00152	CcSEcCtD
Phenytoin—Pharyngitis—Methotrexate—esophageal cancer	0.000153	0.00152	CcSEcCtD
Phenytoin—Discomfort—Capecitabine—esophageal cancer	0.000151	0.0015	CcSEcCtD
Phenytoin—Dry mouth—Capecitabine—esophageal cancer	0.00015	0.00149	CcSEcCtD
Phenytoin—Confusional state—Capecitabine—esophageal cancer	0.000148	0.00147	CcSEcCtD
Phenytoin—Hypersensitivity—Cisplatin—esophageal cancer	0.000147	0.00146	CcSEcCtD
Phenytoin—Infection—Capecitabine—esophageal cancer	0.000146	0.00145	CcSEcCtD
Phenytoin—Erythema multiforme—Methotrexate—esophageal cancer	0.000146	0.00144	CcSEcCtD
Phenytoin—Shock—Capecitabine—esophageal cancer	0.000145	0.00143	CcSEcCtD
Phenytoin—Nervous system disorder—Capecitabine—esophageal cancer	0.000144	0.00143	CcSEcCtD
Phenytoin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000144	0.00143	CcSEcCtD
Phenytoin—Tinnitus—Methotrexate—esophageal cancer	0.000143	0.00142	CcSEcCtD
Phenytoin—Tachycardia—Capecitabine—esophageal cancer	0.000143	0.00142	CcSEcCtD
Phenytoin—Asthenia—Cisplatin—esophageal cancer	0.000143	0.00142	CcSEcCtD
Phenytoin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000142	0.00141	CcSEcCtD
Phenytoin—Anorexia—Capecitabine—esophageal cancer	0.00014	0.00139	CcSEcCtD
Phenytoin—Immune system disorder—Methotrexate—esophageal cancer	0.000139	0.00138	CcSEcCtD
Phenytoin—Chills—Methotrexate—esophageal cancer	0.000138	0.00137	CcSEcCtD
Phenytoin—Hypotension—Capecitabine—esophageal cancer	0.000137	0.00136	CcSEcCtD
Phenytoin—Diarrhoea—Cisplatin—esophageal cancer	0.000136	0.00135	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000134	0.00133	CcSEcCtD
Phenytoin—Insomnia—Capecitabine—esophageal cancer	0.000133	0.00132	CcSEcCtD
Phenytoin—Paraesthesia—Capecitabine—esophageal cancer	0.000132	0.00131	CcSEcCtD
Phenytoin—Dysgeusia—Methotrexate—esophageal cancer	0.000131	0.0013	CcSEcCtD
Phenytoin—Dyspnoea—Capecitabine—esophageal cancer	0.000131	0.0013	CcSEcCtD
Phenytoin—Back pain—Methotrexate—esophageal cancer	0.00013	0.00129	CcSEcCtD
Phenytoin—Dyspepsia—Capecitabine—esophageal cancer	0.000129	0.00128	CcSEcCtD
Phenytoin—Decreased appetite—Capecitabine—esophageal cancer	0.000128	0.00127	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000127	0.00126	CcSEcCtD
Phenytoin—Vomiting—Cisplatin—esophageal cancer	0.000127	0.00126	CcSEcCtD
Phenytoin—Fatigue—Capecitabine—esophageal cancer	0.000127	0.00126	CcSEcCtD
Phenytoin—Rash—Cisplatin—esophageal cancer	0.000126	0.00125	CcSEcCtD
Phenytoin—Constipation—Capecitabine—esophageal cancer	0.000126	0.00125	CcSEcCtD
Phenytoin—Dermatitis—Cisplatin—esophageal cancer	0.000126	0.00125	CcSEcCtD
Phenytoin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000124	0.00123	CcSEcCtD
Phenytoin—Anaemia—Methotrexate—esophageal cancer	0.000124	0.00123	CcSEcCtD
Phenytoin—Feeling abnormal—Capecitabine—esophageal cancer	0.000121	0.0012	CcSEcCtD
Phenytoin—Malaise—Methotrexate—esophageal cancer	0.000121	0.0012	CcSEcCtD
Phenytoin—Vertigo—Methotrexate—esophageal cancer	0.00012	0.00119	CcSEcCtD
Phenytoin—Leukopenia—Methotrexate—esophageal cancer	0.00012	0.00119	CcSEcCtD
Phenytoin—Nausea—Cisplatin—esophageal cancer	0.000118	0.00117	CcSEcCtD
Phenytoin—Cough—Methotrexate—esophageal cancer	0.000117	0.00116	CcSEcCtD
Phenytoin—Urticaria—Capecitabine—esophageal cancer	0.000117	0.00116	CcSEcCtD
Phenytoin—Body temperature increased—Capecitabine—esophageal cancer	0.000116	0.00115	CcSEcCtD
Phenytoin—Convulsion—Methotrexate—esophageal cancer	0.000116	0.00115	CcSEcCtD
Phenytoin—Carbamazepine—ABCB1—esophageal cancer	0.000115	0.0387	CrCbGaD
Phenytoin—Arthralgia—Methotrexate—esophageal cancer	0.000114	0.00113	CcSEcCtD
Phenytoin—Chest pain—Methotrexate—esophageal cancer	0.000114	0.00113	CcSEcCtD
Phenytoin—Myalgia—Methotrexate—esophageal cancer	0.000114	0.00113	CcSEcCtD
Phenytoin—Discomfort—Methotrexate—esophageal cancer	0.000113	0.00112	CcSEcCtD
Phenytoin—Confusional state—Methotrexate—esophageal cancer	0.00011	0.00109	CcSEcCtD
Phenytoin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000109	0.00109	CcSEcCtD
Phenytoin—Infection—Methotrexate—esophageal cancer	0.000109	0.00108	CcSEcCtD
Phenytoin—Hypersensitivity—Capecitabine—esophageal cancer	0.000108	0.00107	CcSEcCtD
Phenytoin—Phenobarbital—ABCB1—esophageal cancer	0.000107	0.036	CrCbGaD
Phenytoin—Nervous system disorder—Methotrexate—esophageal cancer	0.000107	0.00106	CcSEcCtD
Phenytoin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000107	0.00106	CcSEcCtD
Phenytoin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000106	0.00105	CcSEcCtD
Phenytoin—Asthenia—Capecitabine—esophageal cancer	0.000105	0.00105	CcSEcCtD
Phenytoin—Anorexia—Methotrexate—esophageal cancer	0.000104	0.00103	CcSEcCtD
Phenytoin—Pruritus—Capecitabine—esophageal cancer	0.000104	0.00103	CcSEcCtD
Phenytoin—Hypotension—Methotrexate—esophageal cancer	0.000102	0.00101	CcSEcCtD
Phenytoin—Diarrhoea—Capecitabine—esophageal cancer	0.0001	0.000998	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	9.96e-05	0.000989	CcSEcCtD
Phenytoin—Insomnia—Methotrexate—esophageal cancer	9.89e-05	0.000982	CcSEcCtD
Phenytoin—Paraesthesia—Methotrexate—esophageal cancer	9.82e-05	0.000975	CcSEcCtD
Phenytoin—Dyspnoea—Methotrexate—esophageal cancer	9.75e-05	0.000968	CcSEcCtD
Phenytoin—Somnolence—Methotrexate—esophageal cancer	9.72e-05	0.000965	CcSEcCtD
Phenytoin—Dizziness—Capecitabine—esophageal cancer	9.71e-05	0.000964	CcSEcCtD
Phenytoin—Dyspepsia—Methotrexate—esophageal cancer	9.63e-05	0.000955	CcSEcCtD
Phenytoin—Decreased appetite—Methotrexate—esophageal cancer	9.51e-05	0.000944	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Methotrexate—esophageal cancer	9.44e-05	0.000937	CcSEcCtD
Phenytoin—Fatigue—Methotrexate—esophageal cancer	9.43e-05	0.000936	CcSEcCtD
Phenytoin—Vomiting—Capecitabine—esophageal cancer	9.34e-05	0.000927	CcSEcCtD
Phenytoin—Rash—Capecitabine—esophageal cancer	9.26e-05	0.000919	CcSEcCtD
Phenytoin—Dermatitis—Capecitabine—esophageal cancer	9.25e-05	0.000918	CcSEcCtD
Phenytoin—Headache—Capecitabine—esophageal cancer	9.2e-05	0.000913	CcSEcCtD
Phenytoin—Feeling abnormal—Methotrexate—esophageal cancer	9.01e-05	0.000894	CcSEcCtD
Phenytoin—Nausea—Capecitabine—esophageal cancer	8.72e-05	0.000866	CcSEcCtD
Phenytoin—Urticaria—Methotrexate—esophageal cancer	8.69e-05	0.000862	CcSEcCtD
Phenytoin—Body temperature increased—Methotrexate—esophageal cancer	8.64e-05	0.000858	CcSEcCtD
Phenytoin—Hypersensitivity—Methotrexate—esophageal cancer	8.06e-05	0.0008	CcSEcCtD
Phenytoin—Asthenia—Methotrexate—esophageal cancer	7.85e-05	0.000779	CcSEcCtD
Phenytoin—Pruritus—Methotrexate—esophageal cancer	7.74e-05	0.000768	CcSEcCtD
Phenytoin—Diarrhoea—Methotrexate—esophageal cancer	7.48e-05	0.000743	CcSEcCtD
Phenytoin—Dizziness—Methotrexate—esophageal cancer	7.23e-05	0.000718	CcSEcCtD
Phenytoin—Vomiting—Methotrexate—esophageal cancer	6.95e-05	0.00069	CcSEcCtD
Phenytoin—Rash—Methotrexate—esophageal cancer	6.89e-05	0.000684	CcSEcCtD
Phenytoin—Dermatitis—Methotrexate—esophageal cancer	6.89e-05	0.000684	CcSEcCtD
Phenytoin—Headache—Methotrexate—esophageal cancer	6.85e-05	0.00068	CcSEcCtD
Phenytoin—Nausea—Methotrexate—esophageal cancer	6.49e-05	0.000645	CcSEcCtD
Phenytoin—ALB—Metabolism—TYMP—esophageal cancer	1.29e-05	0.000132	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GAPDH—esophageal cancer	1.28e-05	0.000131	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.27e-05	0.00013	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CRABP1—esophageal cancer	1.27e-05	0.00013	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.27e-05	0.00013	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.26e-05	0.000129	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.26e-05	0.000129	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ADH7—esophageal cancer	1.26e-05	0.000129	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYP26A1—esophageal cancer	1.25e-05	0.000128	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GAPDH—esophageal cancer	1.25e-05	0.000128	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.24e-05	0.000127	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CRABP1—esophageal cancer	1.24e-05	0.000127	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.23e-05	0.000126	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ALOX15—esophageal cancer	1.22e-05	0.000125	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.21e-05	0.000124	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GNG7—esophageal cancer	1.2e-05	0.000123	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ADH1B—esophageal cancer	1.18e-05	0.000121	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GNG7—esophageal cancer	1.18e-05	0.000121	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—TPI1—esophageal cancer	1.17e-05	0.00012	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.17e-05	0.00012	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTO1—esophageal cancer	1.17e-05	0.000119	CbGpPWpGaD
Phenytoin—ALB—Metabolism—TPI1—esophageal cancer	1.17e-05	0.000119	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—NOS3—esophageal cancer	1.16e-05	0.000119	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—TYMP—esophageal cancer	1.16e-05	0.000119	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CYP1B1—esophageal cancer	1.16e-05	0.000119	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.16e-05	0.000118	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.15e-05	0.000118	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.15e-05	0.000118	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—TYMP—esophageal cancer	1.13e-05	0.000116	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ALDH2—esophageal cancer	1.13e-05	0.000116	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.13e-05	0.000115	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.12e-05	0.000115	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ALDOB—esophageal cancer	1.12e-05	0.000114	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.11e-05	0.000114	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.1e-05	0.000113	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ALDH2—esophageal cancer	1.1e-05	0.000113	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.1e-05	0.000113	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.1e-05	0.000112	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—NOS2—esophageal cancer	1.09e-05	0.000112	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CYP19A1—esophageal cancer	1.09e-05	0.000111	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.08e-05	0.000111	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.08e-05	0.000111	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GAPDH—esophageal cancer	1.08e-05	0.00011	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GSTT1—esophageal cancer	1.07e-05	0.00011	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.07e-05	0.00011	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ALOX15—esophageal cancer	1.07e-05	0.00011	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CRABP1—esophageal cancer	1.07e-05	0.000109	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CYP2A6—esophageal cancer	1.06e-05	0.000109	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PTGS2—esophageal cancer	1.06e-05	0.000109	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—TYMP—esophageal cancer	1.06e-05	0.000108	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.05e-05	0.000108	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.05e-05	0.000107	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—TPI1—esophageal cancer	1.05e-05	0.000107	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.04e-05	0.000106	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.03e-05	0.000105	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—TPI1—esophageal cancer	1.02e-05	0.000105	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTO1—esophageal cancer	1.02e-05	0.000105	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GNG7—esophageal cancer	1.02e-05	0.000104	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GNG7—esophageal cancer	1.01e-05	0.000104	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ENO1—esophageal cancer	1.01e-05	0.000103	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.01e-05	0.000103	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ALDOB—esophageal cancer	1e-05	0.000103	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ALOX15—esophageal cancer	1e-05	0.000102	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—HMOX1—esophageal cancer	9.93e-06	0.000102	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PSME2—esophageal cancer	9.92e-06	0.000102	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PSME1—esophageal cancer	9.92e-06	0.000102	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ENO1—esophageal cancer	9.84e-06	0.000101	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTGS1—esophageal cancer	9.84e-06	0.000101	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ALDOB—esophageal cancer	9.79e-06	0.0001	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—CREBBP—esophageal cancer	9.78e-06	0.0001	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.77e-06	0.0001	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CA1—esophageal cancer	9.77e-06	0.0001	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PSME2—esophageal cancer	9.69e-06	9.93e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PSME1—esophageal cancer	9.69e-06	9.93e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GAPDH—esophageal cancer	9.66e-06	9.89e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CREBBP—esophageal cancer	9.58e-06	9.81e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CRABP1—esophageal cancer	9.57e-06	9.8e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ALDH2—esophageal cancer	9.56e-06	9.79e-05	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	9.56e-06	9.79e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTO1—esophageal cancer	9.54e-06	9.77e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—TPI1—esophageal cancer	9.54e-06	9.77e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ABCB1—esophageal cancer	9.53e-06	9.76e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ALDH2—esophageal cancer	9.5e-06	9.73e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GAPDH—esophageal cancer	9.43e-06	9.66e-05	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	9.41e-06	9.64e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CRABP1—esophageal cancer	9.34e-06	9.57e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ALDOB—esophageal cancer	9.15e-06	9.37e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GNG7—esophageal cancer	9.1e-06	9.33e-05	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	9.1e-06	9.32e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTT1—esophageal cancer	9.09e-06	9.31e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTT1—esophageal cancer	9.04e-06	9.26e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYP2A6—esophageal cancer	8.99e-06	9.2e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.95e-06	9.17e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYP2A6—esophageal cancer	8.94e-06	9.15e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CA2—esophageal cancer	8.93e-06	9.15e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.9e-06	9.12e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GNG7—esophageal cancer	8.89e-06	9.1e-05	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—EP300—esophageal cancer	8.81e-06	9.03e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GAPDH—esophageal cancer	8.81e-06	9.02e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—NOS3—esophageal cancer	8.75e-06	8.97e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CRABP1—esophageal cancer	8.73e-06	8.94e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—NOS3—esophageal cancer	8.58e-06	8.78e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CYP1B1—esophageal cancer	8.56e-06	8.76e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ALDH2—esophageal cancer	8.53e-06	8.74e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTGS1—esophageal cancer	8.52e-06	8.73e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ENO1—esophageal cancer	8.52e-06	8.73e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ENO1—esophageal cancer	8.47e-06	8.68e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTGS1—esophageal cancer	8.47e-06	8.68e-05	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.46e-06	8.67e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PSME1—esophageal cancer	8.39e-06	8.6e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PSME2—esophageal cancer	8.39e-06	8.6e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CYP1B1—esophageal cancer	8.36e-06	8.57e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PSME2—esophageal cancer	8.35e-06	8.55e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PSME1—esophageal cancer	8.35e-06	8.55e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ALDH2—esophageal cancer	8.33e-06	8.53e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.3e-06	8.51e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ADH7—esophageal cancer	8.3e-06	8.51e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GNG7—esophageal cancer	8.3e-06	8.5e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTT1—esophageal cancer	8.11e-06	8.31e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CYP19A1—esophageal cancer	8.04e-06	8.24e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP2A6—esophageal cancer	8.02e-06	8.22e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.99e-06	8.18e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTT1—esophageal cancer	7.92e-06	8.11e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CYP19A1—esophageal cancer	7.86e-06	8.05e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PTGS2—esophageal cancer	7.84e-06	8.03e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP2A6—esophageal cancer	7.83e-06	8.02e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ALDH2—esophageal cancer	7.78e-06	7.97e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ENO1—esophageal cancer	7.6e-06	7.79e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTGS1—esophageal cancer	7.6e-06	7.79e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PSME1—esophageal cancer	7.49e-06	7.67e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PSME2—esophageal cancer	7.49e-06	7.67e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ENO1—esophageal cancer	7.42e-06	7.6e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTGS1—esophageal cancer	7.42e-06	7.6e-05	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.42e-06	7.6e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTT1—esophageal cancer	7.4e-06	7.58e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—HMOX1—esophageal cancer	7.34e-06	7.52e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.33e-06	7.51e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.31e-06	7.49e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PSME2—esophageal cancer	7.31e-06	7.49e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PSME1—esophageal cancer	7.31e-06	7.49e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.29e-06	7.47e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.29e-06	7.46e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.28e-06	7.46e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYP1B1—esophageal cancer	7.24e-06	7.42e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYP1B1—esophageal cancer	7.2e-06	7.38e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—HMOX1—esophageal cancer	7.18e-06	7.35e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ABCB1—esophageal cancer	7.05e-06	7.22e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TYMP—esophageal cancer	6.96e-06	7.13e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ENO1—esophageal cancer	6.93e-06	7.1e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTGS1—esophageal cancer	6.93e-06	7.1e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ABCB1—esophageal cancer	6.89e-06	7.05e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PSME1—esophageal cancer	6.83e-06	7e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PSME2—esophageal cancer	6.83e-06	7e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYP19A1—esophageal cancer	6.81e-06	6.98e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYP19A1—esophageal cancer	6.77e-06	6.94e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.77e-06	6.93e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—EP300—esophageal cancer	6.66e-06	6.82e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.6e-06	6.76e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.54e-06	6.7e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—EP300—esophageal cancer	6.52e-06	6.68e-05	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PIK3CA—esophageal cancer	6.52e-06	6.68e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP1B1—esophageal cancer	6.47e-06	6.62e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CREBBP—esophageal cancer	6.37e-06	6.52e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP1B1—esophageal cancer	6.31e-06	6.46e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TPI1—esophageal cancer	6.29e-06	6.45e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.29e-06	6.45e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—HMOX1—esophageal cancer	6.21e-06	6.37e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—HMOX1—esophageal cancer	6.18e-06	6.33e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.1e-06	6.24e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP19A1—esophageal cancer	6.08e-06	6.23e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.06e-06	6.21e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.03e-06	6.18e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.97e-06	6.11e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ABCB1—esophageal cancer	5.97e-06	6.11e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP19A1—esophageal cancer	5.93e-06	6.08e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ABCB1—esophageal cancer	5.93e-06	6.08e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP1B1—esophageal cancer	5.9e-06	6.04e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.81e-06	5.95e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.76e-06	5.9e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—NOS3—esophageal cancer	5.7e-06	5.84e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—HMOX1—esophageal cancer	5.55e-06	5.68e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP19A1—esophageal cancer	5.54e-06	5.68e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GNG7—esophageal cancer	5.47e-06	5.61e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.44e-06	5.57e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—HMOX1—esophageal cancer	5.41e-06	5.55e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ABCB1—esophageal cancer	5.32e-06	5.45e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTGS2—esophageal cancer	5.21e-06	5.34e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.13e-06	5.25e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.06e-06	5.18e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.96e-06	5.08e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PIK3CA—esophageal cancer	4.93e-06	5.05e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.88e-06	5e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ABCB1—esophageal cancer	4.85e-06	4.97e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PIK3CA—esophageal cancer	4.83e-06	4.94e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.82e-06	4.94e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—esophageal cancer	4.77e-06	4.88e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CREBBP—esophageal cancer	4.71e-06	4.82e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CREBBP—esophageal cancer	4.6e-06	4.71e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ENO1—esophageal cancer	4.57e-06	4.68e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.57e-06	4.68e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.51e-06	4.62e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PSME2—esophageal cancer	4.51e-06	4.62e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PSME1—esophageal cancer	4.51e-06	4.62e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.48e-06	4.59e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—EP300—esophageal cancer	4.34e-06	4.44e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—NOS3—esophageal cancer	4.22e-06	4.32e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—NOS3—esophageal cancer	4.12e-06	4.22e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.03e-06	4.12e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.99e-06	4.08e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CREBBP—esophageal cancer	3.96e-06	4.06e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.89e-06	3.98e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTGS2—esophageal cancer	3.86e-06	3.95e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.77e-06	3.86e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.67e-06	3.76e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.66e-06	3.74e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NOS3—esophageal cancer	3.57e-06	3.66e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.56e-06	3.64e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NOS3—esophageal cancer	3.55e-06	3.64e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CREBBP—esophageal cancer	3.47e-06	3.56e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.34e-06	3.42e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.26e-06	3.34e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTGS2—esophageal cancer	3.25e-06	3.32e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.24e-06	3.32e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.21e-06	3.29e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—EP300—esophageal cancer	3.21e-06	3.29e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.2e-06	3.28e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NOS3—esophageal cancer	3.19e-06	3.26e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—EP300—esophageal cancer	3.13e-06	3.21e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NOS3—esophageal cancer	3.11e-06	3.19e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.91e-06	2.98e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NOS3—esophageal cancer	2.91e-06	2.98e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTGS2—esophageal cancer	2.84e-06	2.91e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—EP300—esophageal cancer	2.72e-06	2.78e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—EP300—esophageal cancer	2.7e-06	2.77e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.66e-06	2.72e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—EP300—esophageal cancer	2.42e-06	2.48e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CA—esophageal cancer	2.37e-06	2.43e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—EP300—esophageal cancer	2.37e-06	2.42e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.32e-06	2.38e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—EP300—esophageal cancer	2.21e-06	2.26e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.14e-06	2.19e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.01e-06	2.06e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CA—esophageal cancer	2e-06	2.05e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NOS3—esophageal cancer	1.92e-06	1.96e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.79e-06	1.84e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.75e-06	1.79e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.75e-06	1.79e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.63e-06	1.67e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—EP300—esophageal cancer	1.46e-06	1.49e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.08e-06	1.1e-05	CbGpPWpGaD
